Evidence map›Paper›PMID 32330918›Full record

ArticlePhysics in medicine and biology2020

Automated MV markerless tumor tracking for VMAT.

D Ferguson, T Harris, M Shi, M Jacobson, M Myronakis, M Lehmann, P Huber, D Morf, R Fueglistaller, P Baturin and 3 more

Open access · greenAbstract read
In one paragraph

Article in Physics in medicine and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. GPU-accelerated Monte Carlo simulation of MV-CBCT.Physics in medicine and biology · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

D FergusonBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
T HarrisBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
M ShiBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
M JacobsonBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
M MyronakisBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
M LehmannVarian Medical Systems, Baden-Dattwil, Switzerland.
P HuberVarian Medical Systems, Baden-Dattwil, Switzerland.
D MorfVarian Medical Systems, Baden-Dattwil, Switzerland.
R FueglistallerVarian Medical Systems, Baden-Dattwil, Switzerland.
P BaturinVarian Medical Systems, Palo Alto, CA, United States of America.
I Valencia LozanoBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
C WilliamsBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
R BerbecoBrigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, United States of America.
Varian Medical Systems (Switzerland) · CHVarian Medical Systems (United States) · US

Funding

A novel flat-panel detector for advanced on-board radiation therapy imagingR01CA188446 · NCI · DANA-FARBER CANCER INST · PI BERBECO, ROSS I., FUEGLISTALLER, RONY · 2014 to 2024
$7.2M
NCI NIH HHS R01 CA188446
6 · The paper itself

Abstract

Tumor tracking during radiotherapy treatment can improve dose accuracy, conformity and sparing of healthy tissue. Many methods have been introduced to tackle this challenge utilizing multiple imaging modalities, including a template matching based approach using the megavoltage (MV) on-board portal imager demonstrated on 3D conformal treatments. However, the complexity of treatments is evolving with the introduction of VMAT and IMRT, and successful motion management is becoming more important due to a trend towards hypofractionation. We have developed a markerless lung tumor tracking algorithm, utilizing the electronic portal imager (EPID) of the treatment machine. The algorithm has been specifically adapted to track during complex treatment deliveries with gantry and MLC motion. The core of the algorithm is an adaptive template matching method that relies on template stability metrics and local relative orientations to perform multiple feature tracking simultaneously. Only a single image is required to initialize the algorithm and features are automatically added, modified or removed in response to the input images. This algorithm was evaluated against images collected during VMAT arcs of a dynamic thorax phantom. Dynamic phantom images were collected during radiation delivery for multiple lung SBRT breathing traces and an example patient data set. The tracking error was 1.34 mm for the phantom data and 0.68 mm for the patient data. A multi-region, markerless tracking algorithm has been developed, capable of tracking multiple features simultaneously without requiring any other a priori information. This novel approach delivers robust target localization during complex treatment delivery. The reported tracking error is similar to previous reports for 3D conformal treatments.

Indexed as

AlgorithmsAutomationHumansImage Processing, Computer-AssistedLung NeoplasmsMovementPhantoms, ImagingRadiotherapy, Image-GuidedRadiotherapy, Intensity-Modulated

Identifiers

PMID32330918
PMCPMC9107934
OpenAlexW3019174820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.